首页AutophagyEphrin Receptor
Ephrin Receptor
T1448L Dasatinib monohydrate Dasatinib is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of th
T19487 NVP-BHG712 isomer NVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4.
T2456 Tivozanib Tivozanib is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities.
T3476 JI101 JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephri
T4344 ALW-II-41-27 ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
T5451 Ehp-inhibitor-1 Ehp-inhibitor-1 is an Eph family tyrosine kinase inhibitor targeting Eph receptors.
T5452 Ehp-inhibitor-2 Ehp-inhibitor-2 is an Eph family tyrosine kinase inhibitor targeting Eph receptors.
T6348 NVP-BHG712 NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition; also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0
TQ0166 Tesevatinib Tesevatinib (XL-647) is an orally available, multi-target tyrosine kinase inhibitor (IC50s: 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR, ErbB2, KDR, Flt4, and EphB4).
  • 关注公众号
    - 超值特惠
    - 客户福利
    - 业界动态
    - 实用攻略
陶素的所有产品和服务仅用于科学研究,我们不为任何其他用途提供产品和服务(也不为任何个人提供产品和服务)。